Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration



Status:Terminated
Conditions:Skin Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:15 - Any
Updated:2/23/2019
Start Date:November 2014
End Date:June 4, 2018

Use our guide to learn which trials are right for you!

Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)

The purpose of this study is to allow the collection of tissue from subjects to be used in
future research studies by scientists and to isolate tumor fighting cells for the future
treatment of Melanoma.

Inclusion Criteria:

1. Patients must have metastatic melanoma with a resectable metastasis who are undergoing
resection for palliation, therapeutic or curative purpose.

2. Patients must be > 15 years of age and must have metastatic melanoma.

3. Patients must meet standard pre-operative requirements as determined by the surgeon to
be candidates for surgery.

4. Patients must be able to understand and sign the Informed Consent document.

5. Patients must be able to complete the supplemental data form

Exclusion Criteria:

1. women who are pregnant or breastfeeding

2. inability to give consent
We found this trial at
1
site
2200 Santa Monica Blvd
Santa Monica, California 90404
(310) 582-7438
Principal Investigator: Mark B. Faries, M.D.
Phone: 310-582-7456
?
mi
from
Santa Monica, CA
Click here to add this to my saved trials